Dysfunction of GluN3A subunit is involved in depression-like behaviors through synaptic deficits

Mengmeng Zhang,Xiangru Kong,Jing Chen,Wenqin Liu,Can Liu,Xiaoyun Dou,Lin Jiang,Yanmin Luo,Mingrui Song,Peng Miao,Yong Tang,Yun Xiu
DOI: https://doi.org/10.1016/j.jad.2023.03.076
IF: 6.533
2023-03-30
Journal of Affective Disorders
Abstract:Background N -methyl- d -aspartate receptor (NMDAR) has been implicated in the pathophysiology of depression. However, as the unique inhibitory subunit of NMDARs, the role of GluN3A in depression is largely unclear. Methods Firstly, expression of GluN3A was examined in a mouse model of depression induced by chronic restraint stress (CRS). Then, rescue experiment with rAAV-Grin3a injection into hippocampus of CRS mice was carried out. Lastly, GluN3A knockout (KO) mouse was generated via CRISPR/Cas9 technique, and the molecular mechanism underlying involvement of GluN3A in depression was initially explored using RNA-seq technique, RT-PCR and western blotting. Results GluN3A expression in hippocampus was significantly decreased in CRS mice. Depression-like behaviors induced by CRS were ameliorated when the decrease of GluN3A expression in mice exposed to CRS was restored. GluN3A KO mice exhibited symptoms of anhedonia reported as reduced sucrose preference, and symptoms of despair assayed by a longer immobility time in FST. Transcriptome analysis revealed genetic ablation of GluN3A was associated with downregulation of genes implicated in synapse and axon development. Postsynaptic protein PSD95 was decreased in GluN3A KO mice. More importantly, reduction of PSD95 in CRS mice can be rescued by viral mediated Grin3a re-expression. Limitations The mechanism underlying GluN3A involvement in depression is not fully determined. Conclusions Our data suggested that GluN3A dysfunction is involved in depression, which might be mediated by synaptic deficits. These findings will facilitate the understanding of the role of GluN3A in depression, and they might provide a new strategy for the development of subunit-selective NMDAR antagonists as antidepressant drugs.
psychiatry,clinical neurology
What problem does this paper attempt to address?